Abstract:Summary Mucosal‐associated invariant T (MAIT) cells have a semi‐invariant T‐cell receptor that allows recognition of antigen in the context of the MHC class I‐related (MR1) protein. Metabolic intermediates of the riboflavin synthesis pathway have been identified as MR1‐restricted antigens with agonist properties. As riboflavin synthesis occurs in many bacterial species, but not human cells, it has been proposed that the main purpose of MAIT cells is antibacterial surveillance and protection. The majority of human MAIT cells secrete interferon‐gamma (IFNg) upon activation, while some MAIT cells in tissues can also express IL‐17. Given that MAIT cells are present in human barrier tissues colonized by a microbiome, MAIT cells must somehow be able to distinguish colonization from infection to ensure effector functions are only elicited when necessary. Importantly, MAIT cells have additional functional properties, including the potential to contribute to restoring tissue homeostasis by expression of CTLA‐4 and secretion of the cytokine IL‐22. A recent study provided compelling data indicating that the range of human MAIT cell functional properties is explained by plasticity rather than distinct lineages. This further underscores the necessity to better understand how different signals regulate MAIT cell function. In this review, we highlight what is known in regards to activating and inhibitory signals for MAIT cells with a specific focus on signals relevant to healthy and inflamed tissues. We consider the quantity, quality, and the temporal order of these signals on MAIT cell function and discuss the current limitations of computational tools to extrapolate which signals are received by MAIT cells in human tissues. Using lessons learned from conventional CD8 T cells, we also discuss how TCR signals may integrate with cytokine signals in MAIT cells to elicit distinct functional states.

Functions of mucosal associated invariant T cells in eye diseases

Revealing the protective and pathogenic potential of MAIT cells

Regulation of MAIT cells through host-derived antigens

Emerging Roles of Mucosal-Associated Invariant T Cells in Rheumatology

New insights into MAIT cells in autoimmune diseases.

Role of MAIT cells in gastrointestinal tract bacterial infections in humans: more than a gut feeling

Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential

Signals that control MAIT cell function in healthy and inflamed human tissues

Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease

Mucosal‐associated invariant T cells in digestive tract: Local guardians or destroyers?

Mining the multifunction of mucosal-associated invariant T cells in hematological malignancies and transplantation immunity: A promising hexagon soldier in immunomodulatory

Charting MAIT cell development

Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response

Mucosal-associated invariant T cells restrict reactive oxidative damage and preserve meningeal barrier integrity and cognitive function

Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions

Mucosal-associated invariant T cells repress group 2 innate lymphoid cells in Alternaria alternata-induced model of allergic airway inflammation

MAIT Cells: Partners or Enemies in Cancer Immunotherapy?

MAIT cell heterogeneity across paired human tissues reveals specialization of distinct regulatory and enhanced effector profiles

Detection, Expansion, and Isolation of Human MAIT Cells

The MR1/MAIT cell axis in CNS diseases

Development of Ribityllumazine Analogue as Mucosal-Associated Invariant T Cell Ligands